EW Edwards Lifesciences Corp

P/E 52.62
Forward P/E 25.64
Price/Sales 7.82
Beta 0.864
Div Yield --
Market Cap --

Company Analysis

Latest News

Edwards Lifesciences' third quarter EPS of $0.80 beat estimates while company raised 2026 guidance

Edwards Lifesciences reported third quarter results that surpassed consensus expectations for both revenue and earnings, driven by resilient demand in its core...

Edwards Lifesciences Corp Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026

For the third quarter of 2026, analysts expect Edwards Lifesciences to report consensus revenue of $1.68 billion and EPS of $0.74, with the stock currently...

Baillie Gifford significantly increases stake in Edwards Lifesciences

In a recent SEC filing, Baillie Gifford revealed a substantial increase in its holdings of Edwards Lifesciences (EW) during the second quarter of 2026. The...

Viking Global Exits Edwards Lifesciences Stake

Andreas Halvorsen's Viking Global has liquidated its entire position in medical technology firm Edwards Lifesciences (EW). According to a quarterly disclosure...

Edwards Lifesciences raises 2026 sales forecast after second quarter revenue grew 13.6% to $1.74 billion.

Edwards Lifesciences reported second quarter revenue of $1.74 billion and adjusted EPS of $0.78, beating consensus estimates of $1.70 billion and $0.73....

Edwards Lifesciences Corp Q2 2026 Earnings Preview: What Analysts Expect on July 23, 2026

Edwards Lifesciences is expected to report consensus revenue of $1.70 billion and EPS of $0.73 for the second quarter, with the stock currently trading at...

Edwards Lifesciences raises its 2026 outlook after first quarter revenue grew 16.7% driven by strong TAVR performance.

Edwards Lifesciences reported first quarter 2026 revenue of $1.65 billion and adjusted EPS of $0.78, beating analyst estimates. Following the strong results,...

Edwards Lifesciences Corp Q1 2026 Earnings Preview: What Analysts Expect on April 23, 2026

Edwards Lifesciences is expected to post Q1 2026 revenue of $1.58 billion and earnings per share of $0.72, while the stock currently trades at $89.45 against a...